secwatch / observer
8-K filed April 15, 2025, 7:59 PM ET ticker STEX CIK 0001530766
regulatory confidence high sentiment negative materiality 0.65

Streamex Corp. (STEX): Nasdaq/NYSE listing notice — BioSig Technologies receives Nasdaq bid-price deficiency notice; 180-day cure period until Oct 8, 2025

Streamex Corp.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
April 11, 2025, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 27, 2025, through April 10, 2025, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calenda
View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Streamex Corp. filing history →

Source: SEC EDGAR
accession 0001641172-25-004850
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.